Browsing by Author "Barry Jacobson"
Now showing 1 - 11 of 11
- Results Per Page
- Sort Options
Item A case series of factor v leiden mutation in pregnancyJenique Bailly; Barry Jacobson; Susan LouwItem AntiXa monitoring of Apixaban ZyQuis in Venous ThromboEmbolism and Atrial Fibrillation(WILEY-BLACKWELL) Elise Schapkaitz; Byron Ter Morshuizen; Melanie Mc Cree; Barry JacobsonItem A Comprehensive Clinical Assessment of the LumiraDx International Normalized Ratio INR Assay for PointofCare Monitoring in Anticoagulation TherapyRiffat Munir; Elise Schapkaitz; Lara Noble; Sakina Bibi Loonat; Melanie McCree; Nazeer Ali; Barry Jacobson; Wendy Stevens; Lesley ScottItem A Longitudinal Study of Thrombosis and Bleeding Outcomes With Thromboprophylaxis in Pregnant Women at Intermediate and High Risk of VTE(WILEY-BLACKWELL) Elise Schapkaitz; Elena Libhaber; Annika Gerber; Haroun Rhemtula; Jarrod Zamparini; Barry Jacobson; H BullerItem Profile of antiphospholipid antibodies in HIVinfected and HIVuninfected women with a history of thrombosisElise Schapkaitz; Elena Libhaber; Barry Jacobson; Annika Gerber; Haroun Rhemtula; H BullerItem Right heart echocardiography findings in hypoxic pneumonia patients during the COVID19 pandemic in a South African population(OXFORD UNIV PRESS) Sarah Van Blydenstein; Shahed Omar; Barry Jacobson; Colin Menezes; Ruchika MeelItem Safety and Efficacy of Enoxaparin in Pregnancy A Systematic Review and MetaAnalysisBarry Jacobson; Virendra Rambiritch; Dara Paek; Tobias Sayre; Poobalan Naidoo; E et al.Item Selected inflammatory and coagulation biomarkers previral suppression in people with human immunodeficiency virus HIV infection without overt cardiovascular disease Is there a need to redefine reference indices(ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD) Susan Louw; E Mayne; Barry Jacobson; Anthony MayneItem The Novel Coronavirus and Haemostatic abnormalities pathophysiology clinical manifesttations and treatment recommendationsSusan Louw; Barry Jacobson; Elizabeth Mayne; Tracey WiggillThe COVID-19 pandemic, caused by the SARS-C0V-2 virus, was initially considered and managed in a similar manner to the previous SARS epidemic as they are both caused by coronaviruses. What has now become apparent is that a major cause of morbidity and mortality in COVID-19 is abnormal thrombosis. This thrombosis occurs on a macro- and microvascular level and is unique to this disease. The virus has been demonstrated in the endothelium of the pulmonary alveoli and as such is thought to contribute to the devastating respiratory complications encountered. D-dimer concentrations are frequently raised in COVID to levels not frequently seen previously. The optimal anticoagulation treatment in COVID remains to be determined, and the myriad of pathophysiologic effects caused by this virus in the human host have also yet to be fully elucidated.Item Thrombosis AETiology of Aviation-Related Travel: The THETA O Study(WILEY-BLACKWELL) Barry Jacobson; Susan Louw; Elise Schapkaitz; Fatima LaherItem von Willebrand factor propeptidetoantigen ratio in HIVinfected pregnancy Evidence of endothelial activationElise Schapkaitz; Elena Libhaber; Barry Jacobson; Muriel Meiring; Harry R Buller